Peak AI hype seems to have passed. Sobered by reality, formerly breathless futurists can now get a fair hearing when they calmly state the technology really will transform medicine. 

The American College of Cardiology and American Heart Association have issued new guidelines for the management of congenital heart disease in adults. The document outlines how to manage these patients, the challenges they face and much more.

Democrats want to keep Obamacare going. Republicans want to replace it, ideally with health savings accounts. Regardless of which approach holds sway this week—or whenever—either one would be woefully shortsighted. 

When the devices needed for a specific procedure were not available, a group of surgeons got creative. Their one-of-a-kind approach was a success, and the patient has experienced no complications.

Physicians love AI scribes. Has anyone thought to ask patients what they think?

The new guidance, published in JACC, focuses on three classes of commonly used anticancer therapies.

After an official request from Edwards Lifesciences, CMS is rethinking its coverage policy for the use of TAVR to treat asymptomatic severe aortic stenosis. The agency is accepting public comments on this topic until Jan. 14. 

The director of the National Institutes of Health and his principal deputy are touting their success at ‘curing’ the agency of its self-inflicted DEI disability.